VANCOUVER, Aug. 11, 2016 /CNW/ - Aurora Cannabis Inc. (CSE: ACB) (FRANKFURT: 21P) (WKN: A1C4WM) (OTCQB: ACBFF) ("Aurora" or the "Company") is pleased to provide the following operational update.
Continued Rapid Growth in Patient Registration
On August 5, 2016, Aurora surpassed 6,500 active registered patients, exactly seven months after the Company's first sale of product. This is believed to be the fastest rate of patient registration after commencement of commercial operations achieved by any Licensed Producer in Canada.
First $1 Million Month, 24% Month-over-month Sales Growth
Gross revenue for the month of July, 2016 reached $1 million, the first time Aurora has achieved that milestone. Sales of dried cannabis showed strong month-over-month growth, with total weight of product sold in July, 2016 reaching 124,000 grams, versus 100,000 grams sold in June, 2016.
Calgary Same-Day Delivery Successful, Cost-Effective
Launched in May, 2016, same-day delivery of medical cannabis to clients in Calgary and surrounding communities has proven popular and successful. More than 75% of Aurora patients in the Metro Calgary area are now receiving their product orders within 24 hours, through same-day delivery and subsequently-introduced overnight/next-day delivery. In addition, this secure, fast courier delivery program is now serving a critical mass of customers large enough that the cost to Aurora is actually lower than the previously used standard delivery service.
Stockpiling Cannabis Oils
Aurora's extract team has been operating its GMP-compliant CO2 Supercritical Fluid Extraction unit with consistent success, and bottling cannabis oil and storing cannabis concentrate to meet significant anticipated demand once the Company is licensed for oil sales. The Company intends on rolling out a line of ingestible cannabis oils beginning with a high THC oil extracted from Aurora's popular 32% THC strain Warwick #2, and a high CBD oil product extracted from Aurora's flagship 24% CBD product Temple.
"The Aurora Standard continues to deliver," said Terry Booth, CEO. "To grow to over 6,500 registered patients in seven months is unheard of, and has only been possible due to consistent execution on our production, commercial and customer experience strategies."
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot, expandable, state-of-the-art production facility in Mountain View County, Alberta, Canada. Aurora trades on the Canadian Securities Exchange under the symbol "ACB".
On behalf of the Board of Directors, AURORA CANNABIS INC.
Terry Booth, CEO
This news release contains statements about the Company's expectations regarding production capacity, production yields and other aspects of its anticipated future operations that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from the forward-looking statements. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Such factors include but are not limited to the Company's ability to obtain the necessary financing and the general impact of financial market conditions, the yield from marijuana growing operations, product demand, changes in prices of required commodities, competition, government regulations and other risks set out in the Company's management's discussion and analysis filed on SEDAR. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law.
We seek Safe Harbour.
SOURCE Aurora Cannabis Inc.
Image with caption: "Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)". Image available at: http://photos.newswire.ca/images/download/20160811_C7088_PHOTO_EN_751082.jpg
For further information: Cam Battley, Senior VP Communications and Medical Affairs, +1.905.864.5525, firstname.lastname@example.org, www.auroramj.com; Marc Lakmaaker, NATIONAL Equicom, +1.416.848.1397, email@example.com